Edwards Lifesciences and the Antitrust Tax on Quality
Edwards Lifesciences (EW) trades at 30.7x forward earnings with $3.94B in net cash. We evaluate the DOJ antitrust settlement and the SAPIEN 3 RESILIA growth engine.
Edwards Lifesciences (EW) trades at 30.7x forward earnings with $3.94B in net cash. We evaluate the DOJ antitrust settlement and the SAPIEN 3 RESILIA growth engine.